4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsNeoplasms by Site, Thoracic Neoplasms, bronchial disorder, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 32026-09-01NCT07185997
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryArrhythmias, Cardiac, Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, intracerebral hemorrhage, nervous system disorder, vascular disorderRecruitingPhase 32026-05-08NCT03907046
A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid TumorsneoplasmActive, not recruitingPhase 22026-04-22NCT04452955
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of ReductionDisease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, iatrogenic disease, nosocomial infectionRecruitingNot applicable2025-08-15NCT07108660